Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Injectables: SOP for Process Validation

Posted on By

SOP for Process Validation

Standard Operating Procedure for Process Validation

1) Purpose

The purpose of this SOP is to outline the procedures for validating manufacturing processes to ensure they consistently produce products meeting predetermined quality attributes.

2) Scope

This SOP applies to all manufacturing processes within the facility that require validation, including new processes, changes to existing processes, and routine re-validation.

3) Responsibilities

3.1 Validation Manager
– Develop and approve validation protocols and reports.
– Oversee execution of validation activities.
3.2 Production Personnel
Execute validation protocols under specified conditions.
Record data accurately during validation runs.
3.3 Quality Assurance (QA) Personnel
Review and approve validation documentation.
Ensure compliance with regulatory and internal quality requirements.

See also  Injectables: SOP for IT Systems Validation and Data Integrity

4) Procedure

4.1 Validation Planning
4.1.1 Identify processes requiring validation based on risk assessment and regulatory requirements.
4.1.2 Develop a validation master plan outlining the scope, strategy, and schedule of validation activities.
4.2 Protocol Development
4.2.1 Draft validation protocols specifying the objective, scope, acceptance criteria, and methodology.
4.2.2 Obtain approval from QA and relevant stakeholders before execution.
4.3 Execution of Validation Runs
4.3.1 Conduct validation runs according to the approved protocol.
4.3.2 Monitor critical process parameters and record data meticulously.
4.4 Data Analysis
4.4.1 Analyze validation data to verify that the process consistently produces quality products.

/> 4.4.2 Identify and investigate any deviations from acceptance criteria.
4.5 Report Preparation
4.5.1 Compile validation data and findings into a comprehensive report.
4.5.2 Review and approve the validation report, documenting conclusions and recommendations.
4.6 Re-validation
4.6.1 Perform re-validation periodically or when significant changes occur in the process or product.
4.6.2 Follow the same procedures as initial validation for re-validation activities.

See also  SOP for Syringe Labeling and Inspection

5) Abbreviations, if any

– QA: Quality Assurance

6) Documents, if any

– Validation Master Plan
– Validation Protocols
– Validation Reports

7) Reference, if any

– FDA Guidance for Industry: Process Validation: General Principles and Practices
– ICH Q8(R2): Pharmaceutical Development

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: SOP for Metered Dose Inhaler (MDI) Performance Testing
Next Post: SOP for Dry Powder Inhaler (DPI) Performance Testing

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version